These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9723332)

  • 1. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

  • 3. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
    Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
    Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
    Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
    Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
    Maccherini M; Bernazzali S; Diciolla F; Giunti G; Bizzarri F; Lisi GF; Davoli G; Biagioli B; Giomarelli PP; Simeone F; Caciorgna M; Marchetti L; Pula G; Sani G; Toscano M
    Transplant Proc; 1998 Aug; 30(5):1904-5. PubMed ID: 9723327
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute cardiac ongoing rejection: comparison between different strategies.
    Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
    Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
    [No Abstract]   [Full Text] [Related]  

  • 8. Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants.
    Charco R; Vargas V; Balsells J; Lázaro JL; Murio E; Jaurrieta E; Martorell J; Margarit C
    Transplant Proc; 1997; 29(1-2):461-2. PubMed ID: 9123082
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does early steroid withdrawal influence rejection and infection episodes during the first 2 years after heart transplantation?
    Seydoux C; Berguer DG; Stumpe F; Hurni M; Ruchat P; Fischer A; Müller X; Sadeghi H; Goy JJ
    Transplant Proc; 1997; 29(1-2):620-4. PubMed ID: 9123157
    [No Abstract]   [Full Text] [Related]  

  • 11. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract]   [Full Text] [Related]  

  • 13. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation.
    Chien NC; Lin FL; Chou NK; Hsu RB; Wang SS; Chu SH; Ko WJ
    Transplant Proc; 2000 Nov; 32(7):2380-2. PubMed ID: 11120209
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose oral prednisone in the treatment of acute cardiac allograft rejection.
    Delgado JF; Pombo M; Dalmau R; Gómez-Sánchez MA; Escribano P; Lázaro M; Velázquez MT; Sánchez V; Sáenz de la Calzada C; Rufilanchas JJ
    Transplant Proc; 2002 Feb; 34(1):117. PubMed ID: 11959215
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience.
    Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO
    Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.